Spruce Biosciences, Inc. Stock News

Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Spruce Biosciences' (SPRB) CAHmelia-203 phase IIb study of tildacerfont in adult patients with CAH fails to meet the primary efficacy endpoint.

Spruce Biosciences (NASDAQ: SPRB ) stock is falling hard on Thursday after the biopharmaceutical company posted two new updates for investors. The first big update that has investors in SPRB stock re

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocri

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $SPRB--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ra

Analysts like these penny stocks but is it time to buy or not? The post Best Penny Stocks To Buy?

High volume penny stocks to watch right now. The post Penny Stocks To Buy?

SAN FRANCISCO--(BUSINESS WIRE)---- $SPRB #Tildacerfont--Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Spruce Biosciences (SPRB) provided an update on its clinical programs and financials.The company said it accelerating patient recruitment in the CAHmelia studies, which

The stock price of Spruce Biosciences Inc (NASDAQ: SPRB) increased by 13.48% in the most recent trading session. This is why it happened.

Biotech stocks from the Medical sector, including APTO, CELU, CNSP, CYAD and SPRB, might be witnessing a turnaround in 2022 to emerge as solid investment options.

Penny stocks with high short interest gaining plenty of attention in the stock market today. The post Short Squeeze Penny Stocks To Buy For Under $5 If You Like Risk appeared first on Penny Stocks to

Spruce Biosciences Inc. (NASDAQ:SPRB) traded at $3.95 at last check on Tuesday, December 21, made a downward move of -7.38% on its previous days price. Looking at the stock we see that its previous close was $4.27 with the days price range being $3.53 $4.36. In terms of its 52-week price range, SPRB has Investors Take Advantage Of -7.38% Loss In Spruce Biosciences Inc. (NASDAQ: SPRB) Read More »